
Non-Cystic Fibrosis Bronchiectasis Market Research 2025-2035, Competitive Analysis Of Astrazeneca, Sanofi, Insmed, ...
(MENAFN- GlobeNewsWire - Nasdaq) There is a growing emphasis on the development of novel biologic therapies and targeted treatments that address the underlying inflammation and infection that drive the progression of non-cystic fibrosis bronchiectasis. The …